Onderneming Marizyme, Inc. Other OTC
Aandelen
GBSX
US5703721028
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Life Science Technologies
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +176,60% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 1 | 100,0 % | +176,60% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Barthel
CEO | Chief Executive Officer | 67 | 16-11-21 |
George Kovalyov
DFI | Director of Finance/CFO | 39 | 21-12-21 |
Chairman | 71 | 22-02-21 | |
Donald Very
CTO | Chief Tech/Sci/R&D Officer | 66 | 02-12-20 |
Catherine Pachuk
CTO | Chief Tech/Sci/R&D Officer | 68 | 01-07-20 |
Harrison Ross
IRO | Public Communications Contact | 33 | 23-12-21 |
Amar Dhaduk
PRN | Corporate Officer/Principal | - | 01-01-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Barthel
CEO | Chief Executive Officer | 67 | 16-11-21 |
Chairman | 71 | 22-02-21 | |
Terry Brostowin
BRD | Director/Board Member | 65 | 14-12-18 |
Nilesh Patel
BRD | Director/Board Member | 59 | 22-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 131 793 088 | 85 723 766 ( 65,04 %) | 0 | 65,04 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,93% | 123 mld. | |
+17,01% | 111 mld. | |
-7,23% | 23,63 mld. | |
+4,37% | 22,58 mld. | |
-37,63% | 17,61 mld. | |
-6,79% | 17,6 mld. | |
-14,43% | 17,26 mld. | |
+2,17% | 13,55 mld. | |
+24,42% | 11,34 mld. |